JP2009536616A5 - - Google Patents

Download PDF

Info

Publication number
JP2009536616A5
JP2009536616A5 JP2009505429A JP2009505429A JP2009536616A5 JP 2009536616 A5 JP2009536616 A5 JP 2009536616A5 JP 2009505429 A JP2009505429 A JP 2009505429A JP 2009505429 A JP2009505429 A JP 2009505429A JP 2009536616 A5 JP2009536616 A5 JP 2009536616A5
Authority
JP
Japan
Prior art keywords
pain
optionally substituted
butyl
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009505429A
Other languages
English (en)
Japanese (ja)
Other versions
JP5438504B2 (ja
JP2009536616A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/008818 external-priority patent/WO2007120647A2/en
Publication of JP2009536616A publication Critical patent/JP2009536616A/ja
Publication of JP2009536616A5 publication Critical patent/JP2009536616A5/ja
Application granted granted Critical
Publication of JP5438504B2 publication Critical patent/JP5438504B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009505429A 2006-04-11 2007-04-11 電位依存性ナトリウムチャンネル阻害剤として有用である組成物 Active JP5438504B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79107906P 2006-04-11 2006-04-11
US60/791,079 2006-04-11
PCT/US2007/008818 WO2007120647A2 (en) 2006-04-11 2007-04-11 Compositions useful as inhibitors of voltage-gated sodium channels

Publications (3)

Publication Number Publication Date
JP2009536616A JP2009536616A (ja) 2009-10-15
JP2009536616A5 true JP2009536616A5 (enExample) 2011-05-12
JP5438504B2 JP5438504B2 (ja) 2014-03-12

Family

ID=38512589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009505429A Active JP5438504B2 (ja) 2006-04-11 2007-04-11 電位依存性ナトリウムチャンネル阻害剤として有用である組成物

Country Status (13)

Country Link
US (1) US8841483B2 (enExample)
EP (1) EP2004596A2 (enExample)
JP (1) JP5438504B2 (enExample)
KR (1) KR20080109918A (enExample)
CN (1) CN101466665B (enExample)
AU (1) AU2007238857B2 (enExample)
CA (1) CA2648202A1 (enExample)
MX (1) MX2008013194A (enExample)
NO (1) NO20084758L (enExample)
NZ (1) NZ596413A (enExample)
RU (1) RU2470012C2 (enExample)
WO (1) WO2007120647A2 (enExample)
ZA (1) ZA200808751B (enExample)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008281877A1 (en) * 2007-08-02 2009-02-05 F. Hoffmann-La Roche Ag The use of benzamide derivatives for the treatment of CNS disorders
AU2008310663A1 (en) * 2007-10-11 2009-04-16 Vertex Pharmaceuticals Incorporated Aryl amides useful as inhibitors of voltage-gated sodium channels
MX2010003864A (es) * 2007-10-11 2010-06-01 Vertex Pharma Amidas utiles como inhibidores de canales de sodio dependientes de voltaje.
US20110064662A1 (en) * 2007-10-31 2011-03-17 Riken Kit for producing molecular probe for pet screening for drug discovery
US20130039998A1 (en) * 2008-12-24 2013-02-14 University Of Washington Compositions of modulators of the wnt/beta-catenin pathway and benzamide and/or hydroxamic acid derivatives to treat bipolar disorder
ES2879314T3 (es) 2010-08-18 2021-11-22 Biosplice Therapeutics Inc Dicetonas e hidroxicetonas como activadores de la vía de señalización de catenina
US20140113898A1 (en) * 2010-11-08 2014-04-24 Zalicus Pharmaceuticals Ltd. Bisarylsulfone and dialkylarylsulfone compounds as calcium channel blockers
JP6014155B2 (ja) 2011-10-31 2016-10-25 ゼノン・ファーマシューティカルズ・インコーポレイテッドＸｅｎｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． ビアリールエーテルスルホンアミドおよび治療剤としてのそれらの使用
ES2586213T3 (es) 2011-10-31 2016-10-13 Xenon Pharmaceuticals Inc. Compuestos de bencenosulfonamida y su uso como agentes terapéuticos
BR112014029161A2 (pt) * 2012-05-22 2017-06-27 Genentech Inc benzamidas n-substituídas e seu uso no tratamento de dor
BR112015000187A2 (pt) * 2012-07-06 2017-06-27 Genentech Inc benzamidas substituídas com n e métodos de uso das mesmas
ES2857687T3 (es) 2013-01-31 2021-09-29 Vertex Pharma Piridona amidas como moduladores de los canales de sodio
AR094668A1 (es) 2013-01-31 2015-08-19 Vertex Pharma Amidas como moduladores de canales de sodio
CN105073738B (zh) 2013-01-31 2018-01-05 沃泰克斯药物股份有限公司 作为钠通道调节剂的喹啉及喹喔啉酰胺类
PL2968249T3 (pl) 2013-02-22 2019-06-28 Samumed, Llc Gamma-diketony jako aktywatory szlaku sygnałowego Wnt/beta-kateniny
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
BR112015022488A2 (pt) 2013-03-14 2017-07-18 Genentech Inc triazolopiridinas substituídas e métodos de uso das mesmas
BR112015023397A2 (pt) 2013-03-15 2017-07-18 Genentech Inc benzoxazois substituídos e métodos de uso dos mesmos
PE20160548A1 (es) * 2013-07-19 2016-05-21 Vertex Pharma Sulfonamidas como moduladores de canales de sodio
CR20160296A (es) 2013-11-27 2016-09-20 Genentech Inc Benzamidas sustituidas y métodos para usarlas
CA2931550C (en) 2013-12-13 2023-09-26 Vertex Pharmaceuticals Incorporated Prodrugs of pyridone amides useful as modulators of sodium channels
EP3166939B1 (en) 2014-07-07 2019-06-05 Genentech, Inc. Therapeutic compounds and methods of use thereof
US9795550B2 (en) 2014-08-20 2017-10-24 Samumed, Llc Gamma-diketones for treatment and prevention of aging skin and wrinkles
CA2976449C (en) 2015-02-11 2022-08-09 Icahn School Of Medicine At Mount Sinai Benzenesulfonamide upregulators of npc1 for neimann-pick disease and other lysosomal storage disorders
WO2016191312A1 (en) 2015-05-22 2016-12-01 Genentech, Inc. Substituted benzamides and methods of use thereof
EP3101009A1 (en) * 2015-06-05 2016-12-07 Lead Pharma Cel Models IP B.V. Ror gamma (rory) modulators
MA42683A (fr) 2015-08-27 2018-07-04 Genentech Inc Composés thérapeutiques et leurs méthodes utilisation
PE20181003A1 (es) 2015-09-28 2018-06-26 Genentech Inc Compuestos terapeuticos y sus metodos de uso
CN108495851A (zh) 2015-11-25 2018-09-04 基因泰克公司 取代的苯甲酰胺及其使用方法
EP3854782A1 (en) 2016-03-30 2021-07-28 Genentech, Inc. Substituted benzamides and methods of use thereof
WO2018017896A1 (en) * 2016-07-20 2018-01-25 Amgen Inc. Pyridine sulfonamides
SG11201903348UA (en) 2016-10-17 2019-05-30 Genentech Inc Therapeutic compounds and methods of use thereof
US11117858B2 (en) 2017-01-11 2021-09-14 The General Hospital Corporation Voltage gated sodium channel imaging agents
IT201700028127A1 (it) 2017-03-14 2018-09-14 Fondazione St Italiano Tecnologia Composti e composizioni per il trattamento della fibrosi cistica
WO2018175707A1 (en) 2017-03-24 2018-09-27 Genentech, Inc. 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
EP3625214B1 (en) 2017-05-16 2022-07-06 Vertex Pharmaceuticals Incorporated Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
CA3069720A1 (en) 2017-07-11 2019-01-17 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
WO2019157505A1 (en) 2018-02-12 2019-08-15 Vertex Pharmaceuticals Incorporated A method of treating pain
EP3759098A1 (en) 2018-02-26 2021-01-06 Genentech, Inc. Pyridine-sulfonamide compounds and their use against pain and related conditions
EP3774801A1 (en) 2018-03-30 2021-02-17 F. Hoffmann-La Roche AG Fused ring hydro-pyrido compounds as sodium channel inhibitors
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法
KR102860523B1 (ko) * 2018-11-02 2025-09-16 머크 샤프 앤드 돔 엘엘씨 Nav1.8 억제제로서의 2-아미노-n-헤테로아릴-니코틴아미드
WO2020146682A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
WO2020146612A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
TWI770607B (zh) * 2019-09-12 2022-07-11 大陸商上海濟煜醫藥科技有限公司 吡啶氮氧化合物及其製備方法和用途
MX2022006865A (es) 2019-12-06 2022-07-11 Vertex Pharma Tetrahidrofuranos sustituidos como moduladores de canales de sodio.
WO2022121805A1 (zh) * 2020-12-07 2022-06-16 成都康弘药业集团股份有限公司 作为Nav1.8抑制剂的并环化合物及其用途
CN112457294B (zh) * 2021-01-27 2021-06-04 上海济煜医药科技有限公司 一种作为NaV1.8阻滞剂的化合物及其制备方法和用途
CN117794920A (zh) 2021-06-04 2024-03-29 沃泰克斯药物股份有限公司 N-(羟烷基(杂)芳基)四氢呋喃甲酰胺作为钠通道调节剂
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物
CN116947713B (zh) * 2022-04-25 2026-03-27 中国科学院上海药物研究所 并环类化合物及其应用
EP4570788A1 (en) 2022-08-12 2025-06-18 Guangzhou Fermion Technology Co., Ltd. Compound as voltage-gated sodium channel inhibitor
KR20250173577A (ko) * 2023-04-19 2025-12-10 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 Nav1.8억제제 및 이의 제조 방법 및 용도

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130154C (enExample) * 1957-05-29
DE2966048D1 (en) 1978-07-20 1983-09-15 Basf Ag N-arylsulfonyl pyrroles, their preparation and medicaments containing them
US4228449A (en) * 1978-12-26 1980-10-14 Hughes Aircraft Company Semiconductor diode array liquid crystal device
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5716981A (en) 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
DE19804251A1 (de) * 1998-02-04 1999-08-05 Hoechst Marion Roussel De Gmbh Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19830430A1 (de) * 1998-07-08 2000-01-13 Hoechst Marion Roussel De Gmbh Schwefelsubstituierte Sulfonylamino-carbonsäure-N-arylamide, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6620849B2 (en) * 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6995162B2 (en) 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
DE60235114D1 (de) 2001-11-01 2010-03-04 Icagen Inc Pyrazolamide zur anwendung in der behandlung von schmerz
SE0203752D0 (sv) 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
WO2004106324A1 (en) 2003-05-27 2004-12-09 E.I. Dupont De Nemours And Company Azolecarboxamide herbicides
TW200524888A (en) * 2003-08-08 2005-08-01 Vertex Pharma Compositions useful as inhibitors of voltage-gated ion channels
TW200628159A (en) 2004-11-10 2006-08-16 Synta Pharmaceuticals Corp IL-12 modulatory compounds
JP2007045850A (ja) * 2005-08-05 2007-02-22 Tonengeneral Sekiyu Kk 潤滑油組成物
PE20110118A1 (es) 2005-10-04 2011-03-08 Aventis Pharma Inc Compuestos de pirimidina amida como inhibidores de pgds
JP5565999B2 (ja) * 2007-01-31 2014-08-06 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
JP5483662B2 (ja) * 2008-01-15 2014-05-07 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
JP5800448B2 (ja) * 2008-03-25 2015-10-28 Ｊｘ日鉱日石エネルギー株式会社 潤滑油基油及びその製造方法並びに潤滑油組成物
JP5800449B2 (ja) * 2008-03-25 2015-10-28 Ｊｘ日鉱日石エネルギー株式会社 潤滑油基油及びその製造方法並びに潤滑油組成物
JP5806794B2 (ja) * 2008-03-25 2015-11-10 Ｊｘ日鉱日石エネルギー株式会社 内燃機関用潤滑油組成物
SG194403A1 (en) * 2008-10-07 2013-11-29 Jx Nippon Oil & Energy Corp Lubricant base oil and a process for producing the same,and lubricating oil composition
JP2010090251A (ja) * 2008-10-07 2010-04-22 Nippon Oil Corp 潤滑油基油及びその製造方法、潤滑油組成物
US8563486B2 (en) * 2008-10-07 2013-10-22 Jx Nippon Oil & Energy Corporation Lubricant composition and method for producing same
JP5395453B2 (ja) * 2009-02-16 2014-01-22 Ｊｘ日鉱日石エネルギー株式会社 無段変速機油組成物

Similar Documents

Publication Publication Date Title
JP5438504B2 (ja) 電位依存性ナトリウムチャンネル阻害剤として有用である組成物
US8865771B2 (en) Amides useful as inhibitors of voltage-gated sodium channels
US8779197B2 (en) Aryl amides useful as inhibitors of voltage-gated sodium channels
US8343763B2 (en) Heterocyclic derivatives as modulators of ion channels
US7994174B2 (en) Pyridyl sulfonamides as modulators of ion channels
US8097636B2 (en) Heterocyclic derivatives as modulators of ion channels
US20130131109A1 (en) Bicyclic derivatives as modulators of voltage gated ion channels
WO2009064747A2 (en) 4(-3-(-2-(phenyl)morpholino)-2-oxopyrrolidin-1-yl)-n-(thiazol-2-yl)benzenesulfonamide derivati ves and related compounds as modulators of ion channels for the treatment of pain
HK1129096B (en) Compositions useful as inhibitors of voltage-gated sodium channels
HK1130676A (en) Thienopyrimidines useful as modulators of ion channels